Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The HemeScan test for genomic prognostic marker assessment in chronic lymphocytic leukemia.

Gunn SR, Mohammed MS, Mellink CH, Abruzzo LV, Robetorye RS.

Expert Opin Med Diagn. 2008 Jun;2(6):731-40. doi: 10.1517/17530059.2.6.731.

PMID:
23495782
3.

Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.

Gunn SR, Mohammed MS, Gorre ME, Cotter PD, Kim J, Bahler DW, Preobrazhensky SN, Higgins RA, Bolla AR, Ismail SH, de Jong D, Eldering E, van Oers MH, Mellink CH, Keating MJ, Schlette EJ, Abruzzo LV, Robetorye RS.

J Mol Diagn. 2008 Sep;10(5):442-51. doi: 10.2353/jmoldx.2008.080033. Epub 2008 Aug 7.

4.

The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.

Xu X, Johnson EB, Leverton L, Arthur A, Watson Q, Chang FL, Raca G, Laffin JJ.

Cancer Genet. 2013 Sep-Oct;206(9-10):317-26. doi: 10.1016/j.cancergen.2013.09.001. Epub 2013 Oct 24.

PMID:
24269304
5.

Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.

Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Döhner H, Bentz M, Lichter P.

Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):1039-44. Epub 2004 Jan 16.

6.

Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.

Jarosová M, Jedlicková K, Holzerová M, Urbanová R, Papajík T, Raida L, Pikalová Z, Lakomá I, Prekopová I, Kropácková J, Indrák K.

Onkologie. 2001 Feb;24(1):60-5.

PMID:
11441283
7.

Comparative genomic hybridization arrays in clinical pathology: progress and challenges.

Gunn SR, Robetorye RS, Mohammed MS.

Mol Diagn Ther. 2007;11(2):73-7. Review.

PMID:
17397242
8.

Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia.

O'Malley DP, Giudice C, Chang AS, Chang D, Barry TS, Hibbard MK, Chen R, Chen ST.

Int J Lab Hematol. 2011 Jun;33(3):238-44. doi: 10.1111/j.1751-553X.2010.01284.x. Epub 2010 Dec 9.

PMID:
21143592
9.

Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA.

J Mol Diagn. 2010 Mar;12(2):184-96. doi: 10.2353/jmoldx.2010.090118. Epub 2010 Jan 14.

10.

Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.

Patel A, Kang SH, Lennon PA, Li YF, Rao PN, Abruzzo L, Shaw C, Chinault AC, Cheung SW.

Am J Hematol. 2008 Jul;83(7):540-6.

11.

Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?

Puiggros A, Puigdecanet E, Salido M, Ferrer A, Abella E, Gimeno E, Nonell L, Herranz MJ, Galván AB, Rodríguez-Rivera M, Melero C, Pairet S, Bellosillo B, Serrano S, Florensa L, Solé F, Espinet B.

Leuk Lymphoma. 2013 May;54(5):986-95. doi: 10.3109/10428194.2012.731598. Epub 2012 Oct 16.

PMID:
22994157
12.

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.

Rodríguez-Vicente AE, Díaz MG, Hernández-Rivas JM.

Cancer Genet. 2013 Mar;206(3):49-62. doi: 10.1016/j.cancergen.2013.01.003. Epub 2013 Mar 24. Review.

PMID:
23531595
13.

Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.

Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.

Haematologica. 2003 Jul;88(7):769-77.

14.

Molecular biomarkers in chronic lymphocytic leukemia.

Malek S.

Adv Exp Med Biol. 2013;792:193-214. doi: 10.1007/978-1-4614-8051-8_9. Review.

PMID:
24014298
15.

Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN.

Blood. 2011 Sep 15;118(11):3051-61. doi: 10.1182/blood-2010-12-327858. Epub 2011 Jul 27.

16.

Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia.

Zhang L, Znoyko I, Costa LJ, Conlin LK, Daber RD, Self SE, Wolff DJ.

Cancer Genet. 2011 Dec;204(12):654-65. doi: 10.1016/j.cancergen.2011.10.012.

PMID:
22285017
17.

Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.

Rodríguez AE, Robledo C, García JL, González M, Gutiérrez NC, Hernández JA, Sandoval V, García de Coca A, Recio I, Risueño A, Martín-Núñez G, García E, Fisac R, Conde J, de las Rivas J, Hernández JM.

Ann Oncol. 2012 Aug;23(8):2138-46. doi: 10.1093/annonc/mdr579. Epub 2012 Jan 6.

18.

Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group.

Karhu R, Knuutila S, Kallioniemi OP, Siltonen S, Aine R, Vilpo L, Vilpo J.

Genes Chromosomes Cancer. 1997 Aug;19(4):286-90.

PMID:
9258665
19.

Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.

Döhner H, Stilgenbauer S, Fischer K, Schröder M, Bentz M, Lichter P.

Stem Cells. 1995 Dec;13 Suppl 3:76-82. Review.

PMID:
8747992
20.

Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling.

Stevens-Kroef MJ, van den Berg E, Olde Weghuis D, Geurts van Kessel A, Pfundt R, Linssen-Wiersma M, Benjamins M, Dijkhuizen T, Groenen PJ, Simons A.

Mol Cytogenet. 2014 Jan 9;7(1):3. doi: 10.1186/1755-8166-7-3.

Items per page

Supplemental Content

Write to the Help Desk